To stop or not to stop: what should we be doing with biologic DMARDs when patients undergo orthopaedic surgery?
Management of biologic DMARDs in patients undergoing orthopaedic surgery is variable; flare avoidance is a priority.
Main Authors: | van Duren, BH, Wignall, A, Rangan, A, Coates, L, Pandit, H, Mankia, K |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Oxford University Press
2021
|
Similar Items
-
When do stop-loss rules stop losses?
by: Kaminski, Kathryn M., et al.
Published: (2018) -
Will central Wyoming elk stop migrating to Yellowstone, and should we care?
by: Massey, J, et al.
Published: (2013) -
When do apples stop growing, and why does it matter?
by: Christodoulou, M, et al.
Published: (2021) -
Knowing when to stop: futility in the ICU.
by: Wilkinson, D, et al.
Published: (2011) -
Why the NHS should do more bariatric surgery; how much should we do?
by: Welbourn, R, et al.
Published: (2016)